Podcast Episode
View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, William R. Short, MD, MPH, AAHIVS, discusses current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV.
William R. Short, MD, MPH, AAHIVS
Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
Listen to expert faculty discuss strategies to promote ART safety and tolerability in aging patients and populations with cardiometabolic toxicities, from Clinical Care Options (CCO)
Marta Boffito, MD, PhD, FRCP
Jens D. Lundgren, MD, DMSc
Released: January 17, 2023
Dr Christine Katlama discusses minimizing ART exposure with dual-therapy and intermittent dosing strategies, from Clinical Care Options (CCO)
Christine Katlama, MD
Released: January 4, 2023
Listen to Dr Princy Kumar discuss strategies on selecting between first-line ART regimens in treatment-naïve PWH, from Clinical Care Options (CCO)
Princy N. Kumar, MD, FIDSA, MACP
Released: December 29, 2022
Expert HIV faculty analyze new data from AIDS 2022, from Clinical Care Options (CCO)
Joseph J. Eron, Jr., MD
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Princy N. Kumar, MD, FIDSA, MACP
Mary W. Montgomery, MD
David A. Wohl, MD
Physicians:
maximum of 1.5 AMA PRA Category 1 Credits™
Registered Nurses:
1.5 Nursing contact hours
Pharmacists:
1.5 contact hours (0.15 CEUs)
Released: December 23, 2022
Expired:
December 22, 2023
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.